Israel Active

Israel’s Sheba Medical Center plans to open a Longevity Center by Sept 2023. Patients over 40 will be able to register for around $500 per year and receive tests and consultations with experts in internal medicine, endocrinology, psychogeriatric, gynecology for menopause and brain scientists.

Studies by Israeli researchers on patients suffering from post-COVID ailments show that these can be safely relieved by exercise therapy as it stabilizes the autonomic nervous system. Other treatments include nutraceutical supplements, steroids, and hyperbaric oxygen therapy (HBOT).

Scientists from Israel’s Technion Institute and from Japan have discovered peptides (short proteins) with the potential to destroy cancer cells. The scientists made the discovery while researching the cell-recycling protein ubiquitin, that won two Israeli scientists the Nobel Prize in 2004.

The LungFit Nitric Oxide device from Israel’s Beyond Air (see previously) speeds up the recovery of hospitalized COVID patients. Clinical (human) trials showed they needed less oxygen support and spent less time in the hospital than those who didn’t receive the treatment.

The 3-day medical conference “Tomorrow’s Medicine as a Bridge for Peace” in Morocco brought together 60 cancer specialists from Morocco, Israel, and France. It was organized by Pax Medicalis, a France-based nonprofit known in English as the Peace Medical Association.

Israel is a small country, and paramedic training is a priority.  A volunteer EMT from NGO United Hatzalah was walking on the same Netivot street as a man who had a heart attack. The EMT began CPR and was soon joined by another EMT with a defibrillator. Shortly afterwards, the man regained consciousness.

Israel’s Ministry of Health is partnering with Israel’s Lynx MD (see previously) to make patient data from 49 Israeli medical centers available for research. Lynx MD’s medical intelligence platform anonymously secures the data before releasing it to researchers.

Decursin is a substance that promotes hair growth, especially in chemotherapy patients. Decursin is normally extracted from a rare seasonal flower in an expensive process, but students at Israel’s Technion Institute have just won awards by synthesizing it using enzymes from bacteria.

It’s early days, but Tel Aviv University scientists have managed in lab tests to reduce the incidence of breast cancer relapse by 88%. They used two chemotherapies – doxorubicin and cisplatin together, which reduced the spread of cancer cells (metastasis) that occurred using just one therapy.

Israel’s Cuspa Medical is testing the Cusper - a device that takes over the job of a damaged heart valve that can no longer open and close properly to control blood to the heart. The Cusper is inserted using a catheter in a minimally invasive procedure, avoiding major surgery.